263 related articles for article (PubMed ID: 30055088)
1. Area-Level Predictors of Medication Nonadherence Among US Medicaid Beneficiaries With Lupus: A Multilevel Study.
Feldman CH; Costenbader KH; Solomon DH; Subramanian SV; Kawachi I
Arthritis Care Res (Hoboken); 2019 Jul; 71(7):903-913. PubMed ID: 30055088
[TBL] [Abstract][Full Text] [Related]
2. Medication Nonadherence Is Associated With Increased Subsequent Acute Care Utilization Among Medicaid Beneficiaries With Systemic Lupus Erythematosus.
Feldman CH; Yazdany J; Guan H; Solomon DH; Costenbader KH
Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1712-21. PubMed ID: 26097166
[TBL] [Abstract][Full Text] [Related]
3. Dynamic patterns and predictors of hydroxychloroquine nonadherence among Medicaid beneficiaries with systemic lupus erythematosus.
Feldman CH; Collins J; Zhang Z; Subramanian SV; Solomon DH; Kawachi I; Costenbader KH
Semin Arthritis Rheum; 2018 Oct; 48(2):205-213. PubMed ID: 29458974
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Initial Hydroxychloroquine Receipt Among Medicaid Beneficiaries With Incident Systemic Lupus Erythematosus.
Pryor KP; Xu C; Collins JE; Costenbader KH; Feldman CH
Arthritis Care Res (Hoboken); 2022 Aug; 74(8):1263-1268. PubMed ID: 33555101
[TBL] [Abstract][Full Text] [Related]
5. Association between hydroxychloroquine levels and disease activity in a predominantly Hispanic systemic lupus erythematosus cohort.
Geraldino-Pardilla L; Perel-Winkler A; Miceli J; Neville K; Danias G; Nguyen S; Dervieux T; Kapoor T; Giles J; Askanase A
Lupus; 2019 Jun; 28(7):862-867. PubMed ID: 31122136
[TBL] [Abstract][Full Text] [Related]
6. Understanding Nonadherence with Hydroxychloroquine Therapy in Systemic Lupus Erythematosus.
Liu LH; Fevrier HB; Goldfien R; Hemmerling A; Herrinton LJ
J Rheumatol; 2019 Oct; 46(10):1309-1315. PubMed ID: 30709949
[TBL] [Abstract][Full Text] [Related]
7. Racial Differences in Contraception Encounters and Dispensing Among Female Medicaid Beneficiaries With Systemic Lupus Erythematosus.
Williams JN; Xu C; Costenbader KH; Bermas BL; Pace LE; Feldman CH
Arthritis Care Res (Hoboken); 2021 Oct; 73(10):1396-1404. PubMed ID: 32526084
[TBL] [Abstract][Full Text] [Related]
8. Baseline Retinal Examinations in Patients With Systemic Lupus Erythematosus Newly Initiating Hydroxychloroquine Treatment in a US Medicaid Systemic Lupus Erythematosus Population, 2000-2010.
Lin TC; Marmor MF; Barbhaiya M; Guan H; Chen SK; Feldman CH; Costenbader KH
Arthritis Care Res (Hoboken); 2018 Nov; 70(11):1700-1706. PubMed ID: 29409142
[TBL] [Abstract][Full Text] [Related]
9. Azathioprine and Mycophenolate Mofetil Adherence Patterns and Predictors Among Medicaid Beneficiaries With Systemic Lupus Erythematosus.
Feldman CH; Collins J; Zhang Z; Xu C; Subramanian SV; Kawachi I; Solomon DH; Costenbader KH
Arthritis Care Res (Hoboken); 2019 Nov; 71(11):1419-1424. PubMed ID: 30354025
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of Monitoring Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis.
Garg S; Unnithan R; Hansen KE; Costedoat-Chalumeau N; Bartels CM
Arthritis Care Res (Hoboken); 2021 May; 73(5):707-716. PubMed ID: 32004406
[TBL] [Abstract][Full Text] [Related]
11. Adherence to hydroxychloroquine in patients with systemic lupus: Contrasting results and weak correlation between assessment tools.
Hachulla E; Le Gouellec N; Launay D; Balquet MH; Maillard H; Azar R; Boldron A; Bataille P; Lambert M; Buchdahl AL; Allorge D; Hatron PY; Sobanski V; Hennart B; Clerson P; Morell-Dubois S;
Joint Bone Spine; 2020 Dec; 87(6):603-610. PubMed ID: 32438061
[TBL] [Abstract][Full Text] [Related]
12. Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis.
Feldman CH; Hiraki LT; Winkelmayer WC; Marty FM; Franklin JM; Kim SC; Costenbader KH
Arthritis Rheumatol; 2015 Jun; 67(6):1577-85. PubMed ID: 25772621
[TBL] [Abstract][Full Text] [Related]
13. Compliance and persistence with hydroxychloroquine in South Korean patients with systemic lupus erythematosus.
Lee SG; Park EK; Park JH; Kweon SM; Kim YK; Kim GT
Lupus; 2018 Apr; 27(5):753-761. PubMed ID: 29157178
[TBL] [Abstract][Full Text] [Related]
14. Impact of Psychiatric Diagnosis and Treatment on Medication Adherence in Youth With Systemic Lupus Erythematosus.
Chang JC; Davis AM; Klein-Gitelman MS; Cidav Z; Mandell DS; Knight AM
Arthritis Care Res (Hoboken); 2021 Jan; 73(1):30-38. PubMed ID: 32937032
[TBL] [Abstract][Full Text] [Related]
15. Racial/Ethnic variation in all-cause mortality among United States medicaid recipients with systemic lupus erythematosus: a Hispanic and asian paradox.
Gómez-Puerta JA; Barbhaiya M; Guan H; Feldman CH; Alarcón GS; Costenbader KH
Arthritis Rheumatol; 2015 Mar; 67(3):752-60. PubMed ID: 25590668
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004.
Feldman CH; Hiraki LT; Liu J; Fischer MA; Solomon DH; Alarcón GS; Winkelmayer WC; Costenbader KH
Arthritis Rheum; 2013 Mar; 65(3):753-63. PubMed ID: 23203603
[TBL] [Abstract][Full Text] [Related]
17. Health status and concomitant prescription of immunosuppressants are risk factors for hydroxychloroquine non-adherence in systemic lupus patients with prolonged inactive disease.
Iudici M; Pantano I; Fasano S; Pierro L; Charlier B; Pingeon M; Dal Piaz F; Filippelli A; Izzo V
Lupus; 2018 Feb; 27(2):265-272. PubMed ID: 28659047
[TBL] [Abstract][Full Text] [Related]
18. Hydroxychloroquine treatment in a community-based cohort of patients with systemic lupus erythematosus.
Schmajuk G; Yazdany J; Trupin L; Yelin E
Arthritis Care Res (Hoboken); 2010 Mar; 62(3):386-92. PubMed ID: 20391485
[TBL] [Abstract][Full Text] [Related]
19. Hydroxychloroquine and Mortality Among Patients With Systemic Lupus Erythematosus in the General Population.
Jorge A; McCormick N; Lu N; Zheng Y; Esdaile J; De Vera M; Choi H; Aviña-Zubieta JA
Arthritis Care Res (Hoboken); 2021 Aug; 73(8):1219-1223. PubMed ID: 32407570
[TBL] [Abstract][Full Text] [Related]
20. Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study.
Chen YM; Lin CH; Lan TH; Chen HH; Chang SN; Chen YH; Wang JS; Hung WT; Lan JL; Chen DY
Rheumatology (Oxford); 2015 Jul; 54(7):1244-9. PubMed ID: 25587177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
